194 related articles for article (PubMed ID: 29947974)
1. Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study.
Oh SY; Kim WS; Kang HJ; Lee JH; Huh SJ; Kim SJ; Yoon DH; Hong JY; Lee WS; Kim HJ; Won JH; Park BB; Lee SI; Suh C
Ann Hematol; 2018 Oct; 97(10):1851-1857. PubMed ID: 29947974
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
Hashimoto N; Sasaki R; Nishimura H; Yoshida K; Miyawaki D; Nakayama M; Uehara K; Okamoto Y; Ejima Y; Azumi A; Matsui T; Sugimura K
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1509-14. PubMed ID: 21664061
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of tumor-infiltrating FOXP3+ T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Kim KH; Kim TM; Go H; Kim WY; Jeon YK; Lee SH; Kim DW; Khwarg SI; Kim CW; Heo DS
Cancer Sci; 2011 Nov; 102(11):1972-6. PubMed ID: 21812857
[TBL] [Abstract][Full Text] [Related]
4. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.
Paik JS; Cho WK; Lee SE; Choi BO; Jung SE; Park GS; Kim SH; Yang SW; Cho SG
Ann Hematol; 2012 Sep; 91(9):1393-401. PubMed ID: 22543827
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
[TBL] [Abstract][Full Text] [Related]
7. The clinical features of radiation cataract in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Fukutsu K; Kase S; Ishijima K; Kinoshita R; Ishida S
Radiat Oncol; 2018 May; 13(1):95. PubMed ID: 29769097
[TBL] [Abstract][Full Text] [Related]
8. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
9. Risk potentiality of frontline radiotherapy associated cataract in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Cho WK; Lee SE; Paik JS; Cho SG; Yang SW
Korean J Ophthalmol; 2013 Aug; 27(4):243-8. PubMed ID: 23908569
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: long-term results.
Niwa M; Ishikura S; Tatekawa K; Takama N; Miyakawa A; Kubota T; Kato E; Shibamoto Y
Radiat Oncol; 2020 Jan; 15(1):25. PubMed ID: 32000814
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma.
Song EK; Kim SY; Kim TM; Lee KW; Yun T; Na II; Shin H; Lee SH; Kim DW; Khwarg SI; Heo DS
Ann Oncol; 2008 Feb; 19(2):242-6. PubMed ID: 17947227
[TBL] [Abstract][Full Text] [Related]
12. Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
Ejima Y; Sasaki R; Okamoto Y; Maruta T; Azumi A; Hayashi Y; Demizu Y; Ota Y; Soejima T; Sugimura K
Radiother Oncol; 2006 Jan; 78(1):6-9. PubMed ID: 16359744
[TBL] [Abstract][Full Text] [Related]
13. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
[TBL] [Abstract][Full Text] [Related]
14. Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients.
Lim SH; Kang M; Son J
Indian J Ophthalmol; 2011; 59(4):273-7. PubMed ID: 21666310
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prognosis of primary ocular adnexal extranodal marginal zone mucosa-associated lymphoid tissue lymphoma: a report from a single center].
Li X; Ye J; Yang L; Wei LQ; Cong J; Yao N; Yang J; Wang JW
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):209-214. PubMed ID: 35405778
[No Abstract] [Full Text] [Related]
16. Long-term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single-center cohort study.
Liang Y; Fu RY; Liu XL; Liu XD; Piao YS; Ma JM; Wang L
Cancer Med; 2023 Feb; 12(3):2514-2523. PubMed ID: 35906828
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma.
Han JJ; Kim TM; Jeon YK; Kim MK; Khwarg SI; Kim CW; Kim IH; Heo DS
Ann Hematol; 2015 Apr; 94(4):575-81. PubMed ID: 25338969
[TBL] [Abstract][Full Text] [Related]
19. [The clinical features and outcomes in 21 patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma].
Ning F; Ye J; Wei LQ; Li X; Wang JW
Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):784-7. PubMed ID: 23290977
[TBL] [Abstract][Full Text] [Related]
20. Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT Histologies.
Dhakal B; Fenske TS; Ramalingam S; Shuff J; Epperla N; Hosking P; Rein L; Banerjee A; Hari P; D'Souza A; Shah N; Siker M; Griepentrog GJ; Harris GJ; Wells TS; Erickson BA; Hamadani M
Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):305-311.e2. PubMed ID: 28284742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
